SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Raymond James Initiates Coverage On Immunovant with Outperform Rating, Announces Price Target of $35

Raymond James analyst Danielle Brill initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Price Target of $35.

Benzinga · 08/25/2020 10:46
Raymond James analyst Danielle Brill initiates coverage on Immunovant (NASDAQ: IMVT) with a Outperform rating and announces Price Target of $35.